Syngenta settles with Nebraska farmer for ‘rushing’ GMO corn to market before Chinese approval

BN SA P ma M

Syngenta AG reached a confidential settlement with a Nebraska farmer who claimed the company mishandled marketing of its genetically modified seed, causing U.S. corn prices to plummet.

With the settlement, Syngenta averts a trial that was scheduled to start July 10. Terms weren’t disclosed.

[In June 2017], Syngenta lost a $218 million jury verdict for a class of Kansas farmers who brought similar claims against the Swiss agrochemical company, which has been acquired by China National Chemical Corp.

ADVERTISEMENT

Syngenta faces its next class action in a Minnesota court in August, where farmers are seeking more than $600 million.

 …

The farmers claim Syngenta rushed its GMO seed to market before getting approval from China to export the grain there. In 2013, China stopped shipments after calling the corn contaminated by the GMO seed, setting off a five-year depression in prices, the farmers claim. They also allege Syngenta misled them on when the Chinese would approve the seed.

The settlement may not have implications for the rest of the cases, said Anthony Sabino, a law professor at St. John’s University in New York.

ADVERTISEMENT
ADVERTISEMENT

Syngenta has disputed the damages claimed by farmers, or that it did anything wrong. The company didn’t sell the seed until approved by the U.S. and didn’t need Chinese approval, Syngenta lawyers have argued.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Syngenta Settles Farmer’s Contamination Suit Ahead of Trial

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend